Reconsidering early HIV treatment and supervised treatment interruptions - Wikidata - awgldk - TriplyDB

Reconsidering early HIV treatment and supervised treatment interruptions

Reconsidering early HIV treatment and supervised treatment interruptions

http://www.wikidata.org/entity/Q24796745

about

Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia.CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.

P2860

Q30984215-2BBDB811-63F7-48DF-943C-F1D7C480F01E Q35115062-951C5C91-03F1-4984-9E0B-F3CF0FC046F7

P2860

Reconsidering early HIV treatment and supervised treatment interruptions

http://www.wikidata.org/entity/Q24796745

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Reconsidering early HIV treatment and supervised treatment interruptions

@ast

Reconsidering early HIV treatment and supervised treatment interruptions

@en

Reconsidering early HIV treatment and supervised treatment interruptions

@nl

type

label

Reconsidering early HIV treatment and supervised treatment interruptions

@ast

Reconsidering early HIV treatment and supervised treatment interruptions

@en

Reconsidering early HIV treatment and supervised treatment interruptions

@nl

prefLabel

Reconsidering early HIV treatment and supervised treatment interruptions

@ast

Reconsidering early HIV treatment and supervised treatment interruptions

@en

Reconsidering early HIV treatment and supervised treatment interruptions

@nl

P1433

Q24796745-32CF2835-0A87-4511-B226-46AA7E2E6A66

P1476

Q24796745-4433BCF8-DB72-4980-B505-7D6ADDF120E3

P2093

Q24796745-3D91642B-250F-4AA6-9A96-2F936176A39F

P2860

Q24796745-2363ED1D-808C-43AB-AEAA-CB486DB44474

Q24796745-2D252703-3CDC-44EF-B6D6-7E0F9E567294

Q24796745-34503565-E70C-4B68-B5B1-02D30FAB26D7

Q24796745-443319A9-28E8-49E3-BD5D-2AF953171C63

Q24796745-508E2D5A-7DD1-4CD9-8ADF-41C623B4ED7F

Q24796745-539312BC-AED2-45AB-A5BE-25E6C5952E20

Q24796745-76F91D1A-D8ED-448A-9D95-8D32B064B4AB

Q24796745-867C8FB9-CAE0-4BB1-8DA8-539302E5A0D5

Q24796745-9945A553-28B1-42C9-9B30-81FC48DF85D9

Q24796745-A7107D4C-15E5-4D1C-9B47-A2D3A85F47A3

P304

Q24796745-C3AC9127-D1F6-4431-B855-711B9AC00F23

P31

Q24796745-A7322ECA-AF5E-4ACC-866D-C8D8D996123E

P356

Q24796745-48592B8E-919C-4CBD-9636-1EABFEBBEB0D

P407

Q24796745-8E5F1357-03F0-49D1-9BDB-25828D00EC60

P433

Q24796745-6CDD87E9-FCF6-47BE-8C92-214186552DF2

P478

Q24796745-012D0A3B-D823-40BB-8FA3-23689C1ADC56

P577

Q24796745-C3A34A46-23D9-4E2B-AAF8-BE2C9A34A68A

P5875

Q24796745-8A717FBF-A670-42EF-AD44-A1924EBEA0FA

P698

Q24796745-30586563-1A45-437D-B8A5-BE7A1CAE9110

P932

Q24796745-72610CC2-EBF1-44D0-9D36-44D9F7326030

P356

JOURNAL.PMED.0010041

P1433

P1476

Reconsidering early HIV treatment and supervised treatment interruptions

@en

P2093

Richard A Koup

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Limited durability of viral control following treated acute HIV infection

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

HIV preferentially infects HIV-specific CD4+ T cells.

Structured treatment interruptions to control HIV-1 and limit drug exposure.

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.

HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.

Control of HIV despite the Discontinuation of Antiretroviral Therapy

P304

e41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.0010041

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8149813

http://www.w3.org/2001/XMLSchema#string

P698

15578109

http://www.w3.org/2001/XMLSchema#string

P932

529427

http://www.w3.org/2001/XMLSchema#string